Literature DB >> 9093628

The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis.

R A Seaton1, N Verma, S Naraqi, J P Wembri, D A Warrell.   

Abstract

In Papua New Guinea visual loss is a frequent sequal to Cryptococcus neoformans var. gattii meningitis in immunocompetent patients. We have previously postulated that visual loss may occur as a result of the immunological response to infection around the optic nerve. This retrospective study set out to explore the effect of corticosteroids on visual outcome. Sixteen patients received varying doses of corticosteroid (mainly 100-250 mg of hydrocortisone daily for the prevention of febrile reactions to amphotericin) and 10 received anticryptococcal therapy alone. Visual deterioration occurred less frequently in those treated with corticosteroids (2/16 [12.5%] vs. 7/10 [70%], P = 0.007), blindness was less frequent (1/16 [5.3%] vs. 5/10 [50%], P = 0.018), and in 3 patients vision improved. Corticosteroids may have a role in preventing or halting visual loss in C. neoformans var. gattii meningitis in immunocompetent patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093628     DOI: 10.1016/s0035-9203(97)90393-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  22 in total

Review 1.  Cryptococcosis diagnosis and treatment: What do we know now.

Authors:  John R Perfect; Tihana Bicanic
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

2.  Bilateral optic neuropathy associated with cryptococcal meningitis in an immunocompetent patient.

Authors:  Joana Portelinha; Maria Picoto Passarinho; Ana Catarina Almeida; João Marques Costa
Journal:  BMJ Case Rep       Date:  2014-06-11

Review 3.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis.

Authors:  Gautam U Mehta; Anil A Panackal; Roger Murayi; John E Bennett; Peter R Williamson; Prashant Chittiboina
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-26       Impact factor: 10.154

5.  Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications.

Authors:  D A Stevens; D W Denning; S Shatsky; R W Armstrong; J D Adler; B H Lewis
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 6.  Management of Cryptococcus gattii meningoencephalitis.

Authors:  Carlos Franco-Paredes; Tanea Womack; Teri Bohlmeyer; Brenda Sellers; Allison Hays; Kalpesh Patel; Jairo Lizarazo; Shawn R Lockhart; Wajid Siddiqui; Kieren A Marr
Journal:  Lancet Infect Dis       Date:  2014-11-26       Impact factor: 25.071

7.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

Review 8.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

9.  Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.

Authors:  Justin Beardsley; Marcel Wolbers; Freddie M Kibengo; Abu-Baker M Ggayi; Anatoli Kamali; Ngo Thi Kim Cuc; Tran Quang Binh; Nguyen Van Vinh Chau; Jeremy Farrar; Laura Merson; Lan Phuong; Guy Thwaites; Nguyen Van Kinh; Pham Thanh Thuy; Wirongrong Chierakul; Suwatthiya Siriboon; Ekkachai Thiansukhon; Satrirat Onsanit; Watthanapong Supphamongkholchaikul; Adrienne K Chan; Robert Heyderman; Edson Mwinjiwa; Joep J van Oosterhout; Darma Imran; Hasan Basri; Mayfong Mayxay; David Dance; Prasith Phimmasone; Sayaphet Rattanavong; David G Lalloo; Jeremy N Day
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

10.  Ophthalmic manifestations of Cryptococcus gattii species complex: a case series and review of the literature.

Authors:  Grace A McCabe; Jack W McHugh; Todd Goodwin; Douglas F Johnson; Anthony Fok; Thomas G Campbell
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.